Bio-Techne Corporation (BVMF:T1CH34)

Brazil flag Brazil · Delayed Price · Currency is BRL
12.11
0.00 (0.00%)
At close: Nov 26, 2025
-7.42%
Market Cap 52.46B
Revenue (ttm) 6.48B
Net Income (ttm) 415.42M
Shares Out n/a
EPS (ttm) 2.59
PE Ratio 126.28
Forward PE 30.69
Dividend 0.04 (0.33%)
Ex-Dividend Date Nov 14, 2025
Volume 5
Average Volume 49
Open 12.11
Previous Close n/a
Day's Range 12.11 - 12.11
52-Week Range 8.92 - 16.38
Beta 1.47
RSI 54.64
Earnings Date Jan 30, 2026

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue cultur... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1976
Employees 3,100
Stock Exchange Brazil Stock Exchange
Ticker Symbol T1CH34
Full Company Profile

Financial Performance

In 2025, Bio-Techne's revenue was $1.22 billion, an increase of 5.23% compared to the previous year's $1.16 billion. Earnings were $73.36 million, a decrease of -56.35%.

Financial numbers in USD Financial Statements

News

There is no news available yet.